SEC Filing Summary: TD SYNNEX CORP (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SYNNEX Corporation (now TD SYNNEX Corp) on January 20, 2021. The filing discloses executive compensation arrangements, specifically the granting of long-term incentive awards and amendments to employment offer letters for key officers. The report notes the recent completion of the spin-off of the Concentrix business on December 1, 2020.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on corporate governance and executive compensation details.
Material Changes and Executive Compensation
- Long-Term Incentive (LTI) Grants: On January 20, 2021, the Compensation Committee granted performance-based restricted stock units (RSUs) to four executive officers under two programs: 2021-2022 and 2021-2023.
- Dennis Polk (CEO): 7,947 shares per program.
- Michael Urban: 4,823 shares per program.
- Peter Larocque: 4,735 shares per program.
- Marshall Witt: 2,740 shares per program.
- Vesting Criteria: Vesting is contingent upon cumulative Earnings Per Share (EPS) and Return on Invested Capital (ROIC) performance. The maximum payout is 200% of the target, while the minimum threshold is 75%. If the minimum EPS threshold is not met, no RSUs vest.
- Employment Agreement Amendments:
- Dennis Polk: An amendment to his offer letter provides for the acceleration of 80% of unvested equity awards (excluding performance-based RSUs and recent grants) upon termination without cause, disability, or death.
- Peter Larocque: A new offer letter provides for the acceleration of all unvested equity awards (excluding performance-based RSUs and recent grants) upon termination without cause, disability, or death on or after December 1, 2023.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook statements, or a discussion of general business risks. The primary contingency noted is the vesting of equity awards, which is strictly dependent on the achievement of specific financial performance metrics (EPS and ROIC) and continued employment.
Key Facts for Investor Verification
- Verify the specific EPS and ROIC targets set for the 2021-2022 and 2021-2023 performance periods to assess the likelihood of maximum vesting.
- Review the full text of the Amendment to Offer Letter (Exhibit 10.1) and Offer Letter (Exhibit 10.2) to understand the specific conditions and definitions of "cause" and "disability."
- Confirm the impact of the Concentrix spin-off on the company's future financial reporting and executive compensation structure.
- Monitor future filings for actual performance results against the EPS and ROIC thresholds to determine the final value of the granted RSUs.